DB28582InvestigationalProtein Based Therapies
VIR-5818 is a biologic drug. VIR-5818 is under investigation in clinical trial NCT05356741 (To Access the Safety and Effects of Intravenous Administration of VIR-5818 Alone and in Combination With Pembrolizumab...
- Code names
- AMX-818 · VIR-5818
What you can answer from here — as of August 25, 2026
Which companies are running trials of VIR-5818, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account